BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GC Cell Hosts Landmark Symposium in Indonesia to Spotlight Immuncell-LC Cancer Immunotherapy

GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia....

January 24, 2025 | News

GI Innovation and LaNova Medicines Join Forces for Breakthrough Pancreatic Cancer Combination Therapy

GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development o...

January 23, 2025 | News

Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carcinoma

Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

January 21, 2025 | News

Innovent and ASK Pharm Secure NMPA Approval for Limertinib in EGFR T790M-Mutated NSCLC

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

January 20, 2025 | News

Innovent and ASK Pharm Secure NMPA Approval for Limertinib to Treat EGFR T790M-Mutated NSCLC

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Brunei MOH and BGI Genomics Unite to Launch National Cervical Cancer Prevention Program

Brunei Ministry of Health (MOH), in partnership with Borneo Genomics Innovation (BGIB), a joint venture of BGI Genomics in Brunei, launched the Nation...

January 17, 2025 | News

Simcere Zaiming and AbbVie Partner to Advance Novel Trispecific Antibody for Multiple Myeloma Treatment

Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement ...

January 14, 2025 | News

SN BioScience Secures FDA IND Clearance for SNB-101 Phase 1b/2 Trial, Targeting Extensive Stage Small Cell Lung Cancer

SN BioScience announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administra...

January 13, 2025 | News

Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...

January 13, 2025 | News

Biocytogen and Acepodia Join Forces to Advance Precision Oncology with Dual-Payload Bispecific ADCs

Collaboration initiates development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs) Biocytogen’s RenLite® meets Acepodia’s...

January 08, 2025 | News

Dizal’s China-Origin Sunvozertinib Secures FDA Priority Review for EGFR Exon20ins NSCLC

If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with E...

January 08, 2025 | News

GORTEC's Phase 3 Trial Shows Nivolumab Improves Disease-Free Survival in High-Risk Head and Neck Cancer Patients

GORTEC, known as Head and Neck Radiation Oncology Group, announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, ...

January 08, 2025 | News

Stay Connected